Skyepharma is a drug delivery company developing oral and inhalation products. Its proprietary drug delivery technologies enable the development of new formulations of existing products as well as new chemical entities to provide a clinical benefit to patients. The company develops Geomatrix and Geoclock technologies that enable controlled- or timed-release versions of immediate-release products to be developed providing advantages to both partner companies and patients.